Research spawns 200 jobs

March 18, 2005

Swansea University plans to recruit 100 researchers to work in its new Pounds 50 million Institute of Life Sciences, and is expecting at least another 100 jobs to be created through related spin-off firms.

Recruitment of researchers is planned to start when the institute, which will house one of the fastest computers in the world, opens next year.

Swansea says it will be looking for people prepared to work in an interdisciplinary environment and with expertise in a wide range of areas.

Research posts will be created over the next five years, during which time about 30 spin-off companies are expected to be formed. The institute, part-funded by the Welsh Development Agency, the Welsh European Funding Office and IBM, will support research into ways of treating diseases and delivering healthcare.

It will host a European Deep Computing Visualisation Centre for Medical Applications, including IBM's supercomputer "Blue C".

Julian Hopkin, head of the institute and of Swansea's School of Medicine, said: "It will help us identify new solutions to existing problems in mainstream diseases such as diabetes, cancer and cardiac ailments."

Richard Davies, Swansea's vice-chancellor, said: "By creating a world-class facility we have a sustainable engine for the knowledge economy, working with spin-off companies and attracting inward investment."

Please login or register to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments

Most commented

Recent controversy over the future directions of both Stanford and Melbourne university presses have raised questions about the role of in-house publishing arms in a world of commercialisation, impact agendas, alternative facts – and ever-diminishing monograph sales. Anna McKie reports

3 October